An expert consensus on the adjustment of treatment strategies in patients with chronic hepatitis B treated with non-first-line nucleos(t)ide analogues
- Author:
1
;
2
Author Information
- Publication Type:Journal Article
- Keywords: nucleos(t)ide analogues; hepatitis B,chronic; experienced treatment; treatment strategy; consensus
- From: Chinese Journal of Practical Internal Medicine 2019;39(06):529-532
- CountryChina
- Language:Chinese
- Abstract: Oral nucleos(t)ide analogues(NAs) is one of the main and efficient way for the treatment of chronic hepatitis B(CHB).Considering the antiviral potency of drugs and drug resistance, in the domestic and foreign guidelines, NAs are divided into first-line and non-first-line drugs. “An Expert Consensus on the Adjustment of Treatment Strategies in Patients with Chronic Hepatitis B Treated with Non-first-line Nucleos(t)ide Analogues” is mainly aimed at those patients who are currently using non-first-line NAs drugs. In addition,the folliwing is presented: how to standardize the adjustment to first-line NAs drugs of choice, how to strengthen the effectiveness of initial antiviral treatment to obtain better antiviral efficacy and improve patient compliance, and at the same time avoid occurrence of serious drug adverse reactions in patients with CHB.
